Bouvet V - Search Results

1

Erratum: Automated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer.

Bouvet V, Jans HS, Wuest M, Soueidan OM, Grant T, Mercer J, McEwan AJ, West FG, Cheeseman CI, Wuest F. Bouvet V, et al. Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):95. eCollection 2015. Am J Nucl Med Mol Imaging. 2014. PMID: 25625031 Free PMC article.

2

Automated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer.

Bouvet V, Jans HS, Wuest M, Soueidan OM, Mercer J, McEwan AJ, West FG, Cheeseman CI, Wuest F. Bouvet V, et al. Am J Nucl Med Mol Imaging. 2014 Apr 25;4(3):248-59. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 24795839 Free PMC article.

3

Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice.

Wuest M, Hamann I, Bouvet V, Glubrecht D, Marshall A, Trayner B, Soueidan OM, Krys D, Wagner M, Cheeseman C, West F, Wuest F. Wuest M, et al. Among authors: bouvet v. Mol Pharmacol. 2018 Feb;93(2):79-89. doi: 10.1124/mol.117.110007. Epub 2017 Nov 15. Mol Pharmacol. 2018. PMID: 29142019

4

Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole using microfluidic technology.

Bouvet VR, Wuest M, Wiebe LI, Wuest F. Bouvet VR, et al. Nucl Med Biol. 2011 Feb;38(2):235-45. doi: 10.1016/j.nucmedbio.2010.09.002. Epub 2010 Dec 3. Nucl Med Biol. 2011. PMID: 21315279

5

Synthesis and pre-clinical evaluation of an (18)F-labeled single-chain antibody fragment for PET imaging of epithelial ovarian cancer.

Sharma SK, Wuest M, Way JD, Bouvet VR, Wang M, Wuest FR. Sharma SK, et al. Among authors: bouvet vr. Am J Nucl Med Mol Imaging. 2016 Jul 6;6(3):185-98. eCollection 2016. Am J Nucl Med Mol Imaging. 2016. PMID: 27508105 Free PMC article.

6

Copper-free click chemistry with the short-lived positron emitter fluorine-18.

Bouvet V, Wuest M, Wuest F. Bouvet V, et al. Org Biomol Chem. 2011 Nov 7;9(21):7393-9. doi: 10.1039/c1ob06034a. Epub 2011 Sep 22. Org Biomol Chem. 2011. PMID: 21938294

7

Microfluidic technology: an economical and versatile approach for the synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET).

Bouvet V, Wuest M, Tam PH, Wang M, Wuest F. Bouvet V, et al. Bioorg Med Chem Lett. 2012 Mar 15;22(6):2291-5. doi: 10.1016/j.bmcl.2012.01.083. Epub 2012 Feb 2. Bioorg Med Chem Lett. 2012. PMID: 22342141

8

Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models.

Bouvet V, Wuest M, Jans HS, Janzen N, Genady AR, Valliant JF, Benard F, Wuest F. Bouvet V, et al. EJNMMI Res. 2016 Dec;6(1):40. doi: 10.1186/s13550-016-0195-6. Epub 2016 May 4. EJNMMI Res. 2016. PMID: 27142881 Free PMC article.

9

Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile.

Bouvet V, Wuest M, Bailey JJ, Bergman C, Janzen N, Valliant JF, Wuest F. Bouvet V, et al. Mol Imaging Biol. 2017 Dec;19(6):923-932. doi: 10.1007/s11307-017-1102-x. Mol Imaging Biol. 2017. PMID: 28639122

10

Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.

Hamann I, Krys D, Glubrecht D, Bouvet V, Marshall A, Vos L, Mackey JR, Wuest M, Wuest F. Hamann I, et al. Among authors: bouvet v. FASEB J. 2018 Sep;32(9):5104-5118. doi: 10.1096/fj.201800360R. Epub 2018 Apr 13. FASEB J. 2018. PMID: 29913554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters